External validation of two nomograms for predicting patient survival after hepatic resection for metastatic colorectal cancer

World Journal of Surgery

Volumn 35, Issue 10, 2011, Pages 2275-2282

  Takakura, Yuji ^a   Okajima, Masazumi ^b   Kanemitsu, Yukihide ^c   Kuroda, Shintaro ^a   Egi, Hiroyuki ^a   Hinoi, Takao ^a   Tashiro, Hirotaka ^a   Ohdan, Hideki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLORECTAL TUMOR; FEMALE; HUMAN; LIVER RESECTION; LIVER TUMOR; MALE; MORTALITY; NOTE; PATHOLOGY; STATISTICAL MODEL;

COLORECTAL NEOPLASMS; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MODELS, STATISTICAL;

EID: 80855132192     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-011-1194-4     Document Type: Article

References (26)

1. Benoist S, Nordlinger B (2009) The role of preoperative chemotherapy in patients with resectable colorectal liver metastases. Ann Surg Oncol 16:2385-2390
2. Nordlinger B, Sorbye H, Glimelius B et al (2008) Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup Trial 40983): a randomised controlled trial. Lancet 371:1007-1016 (Pubitemid 351392040)
3. Iwatsuki S, Dvorchik I, Madariaga JR et al (1999) Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg 189:291-299 (Pubitemid 29408866)
4. Fong Y, Fortner J, Sun RL et al (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230:309-318 (discussion 318-321)
5. Rees M, Tekkis PP, Welsh FK et al (2008) Evaluation of longterm survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg 247: 125-135
6. Nordlinger B, Guiguet M, Vaillant JC et al (1996) Surgical resection of colorectal carcinoma metastases to the liver: a prognostic scoring system to improve case selection, based on 1568 patients: Association Francaise de Chirurgie. Cancer 77:1254-1262 (Pubitemid 26102322)
7. Minagawa M, Yamamoto J, Kosuge T et al (2007) Simplified staging system for predicting the prognosis of patients with resectable liver metastasis: development and validation. Arch Surg 142:269-276 (discussion 277) (Pubitemid 46457054)
8. Mala T, Bohler G, Mathisen O et al (2002) Hepatic resection for colorectal metastases: can preoperative scoring predict patient outcome? World J Surg 26:1348-1353. doi:10.1007/s00268-002-6231-x (Pubitemid 36920229)
9. Merkel S, Bialecki D, Meyer T et al (2009) Comparison of clinical risk scores predicting prognosis after resection of colorectal liver metastases. J Surg Oncol 100:349-357
10. Mann CD, Metcalfe MS, Leopardi LN et al (2004) The clinical risk score: emerging as a reliable preoperative prognostic index in hepatectomy for colorectal metastases. Arch Surg 139:1168-1172 (Pubitemid 39463447)
11. Yamaguchi T, Mori T, Takahashi K et al (2008) A new classification system for liver metastases from colorectal cancer in Japanese multicenter analysis. Hepatogastroenterology 55:173-178 (Pubitemid 351462185)
12. Kattan MW, Heller G, Brennan MF (2003) A competing-risks nomogram for sarcoma-specific death following local recurrence. Stat Med 22:3515-3525 (Pubitemid 37407347)
13. Kattan MW, Karpeh MS, Mazumdar M et al (2003) Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol 21:3647-3650 (Pubitemid 46594058)
14. Brennan MF, Kattan MW, Klimstra D et al (2004) Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg 240:293-298 (Pubitemid 38963021)
15. Cagiannos I, Karakiewicz P, Eastham JA et al (2003) A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. J Urol 170:1798-1803 (Pubitemid 37254931)
16. Diblasio CJ, Kattan MW (2003) Use of nomograms to predict the risk of disease recurrence after definitive local therapy for prostate cancer. Urology 62(Suppl 1):9-18 (Pubitemid 41116559)
17. Kattan MW (2003) Nomograms are superior to staging and risk grouping systems for identifying high-risk patients: preoperative application in prostate cancer. Curr Opin Urol 13:111-116 (Pubitemid 36288341)
18. Kattan MW, Zelefsky MJ, Kupelian PA et al (2003) Pretreatment nomogram that predicts 5-year probability of metastasis following three-dimensional conformal radiation therapy for localized prostate cancer. J Clin Oncol 21:4568-4571 (Pubitemid 46594028)
19. Kattan MW, Reuter V, Motzer RJ et al (2001) A postoperative prognostic nomogram for renal cell carcinoma. J Urol 166:63-67 (Pubitemid 32565343)
20. Van Zee KJ, Manasseh DM, Bevilacqua JL et al (2003) A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 10:1140-1151 (Pubitemid 40486808)
21. Kattan MW, Gonen M, Jarnagin WR et al (2008) A nomogram for predicting disease-specific survival after hepatic resection for metastatic colorectal cancer. Ann Surg 247:282-287 (Pubitemid 351156771)
22. Kanemitsu Y, Kato T (2008) Prognostic models for predicting death after hepatectomy in individuals with hepatic metastases from colorectal cancer. World J Surg 32:1097-1107. doi: 10.1007/s00268-007-9348-0
23. Giacchetti S, Itzhaki M, Gruia G et al (1999) Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol 10:663-669 (Pubitemid 29342371)
24. Simmonds PC, Primrose JN, Colquitt JL et al (2006) Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer 94:982-999
25. De Jong MC, Mayo SC, Pulitano C et al (2009) Repeat curative intent liver surgery is safe and effective for recurrent colorectal liver metastasis: results from an international multi-institutional analysis. J Gastrointest Surg 13:2141-2151
26. Van Cutsem E, Rivera F, Berry S et al (2009) Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study. Ann Oncol 20:1842-1847